Author: admin-occhiena



ACROBiosystems is an international leader in recombinant protein industry, specialized in producing high quality biomarkers for drug discovery. The latest focus of ACROBiosystems is the emerging field of cancer immunotherapy. The company has developed an exclusive immune checkpoint product line that includes all known checkpoint proteins of humans and commonly used experimental animal species. All [...]
October 12, 2015 News & Eventi

Funakoshi Co., Ltd.

It is with great satisfaction that Valter Occhiena S.r.l. announce its new distribution agreement for the Italian territory with Funakoshi Co., Ltd. (Tokyo, Japan). Funakoshi has contributed as a leader to distribute research reagents and instruments for researchers in the life science fields since its foundation. The corporate mission is to provide products to broad [...]
October 2, 2015 News & Eventi

Bio-Byblos Biomedical Co., Ltd.

Bio-Byblos Biomedical Co. (also known as BBBMD) is a Taiwan-based biomedical company venturing new technology in biomedical science and technology. Fully understood the current needs in tissue engineering and regenerative medicine, they are actively looking for new alternative of culturing cells in three dimensional matrix to recapitulate cellular physiological microenvironments in vitro. Among various abundantly [...]
September 24, 2015 News & Eventi


DENDRITICS, innovative tools around dendritics cells, was started in 2005 by former members of Schering Plough Laboratory for Immunological Research (LIR) in Dardilly, France. In the first years they supplied a large collection of monoclonal antibodies, most of them directly resulted from their participation in gene discovery programs and functional studies they had developed at [...]
September 16, 2015 News & Eventi
1 2